Benjamin Graham fit · Defensive deep-value investing
Is Takeda Pharmaceutical Company Limited (4502.T) a Benjamin Graham Stock?
Meets 4/7 Graham criteria - partially qualifies.
54/100
CMixed signals
4/7 criteria passed
Benjamin Graham's Criteria, Applied to 4502.T
P/E ≤ 15
key74.9x
P/B ≤ 1.5
key1.2x
Current ratio ≥ 2
1.0x
Debt / Equity ≤ 1
0.7x
5y profitable
keyYes
Earnings yield ≥ 7%
1.3%
Revenue growing
8.7%
How 4502.T Scores on Other Strategies
Live Financial Snapshot
Market cap
$8.09T
P/E (TTM)
74.9x
ROIC (TTM)
1.91%
Gross margin
65.51%
Other Benjamin Graham fit reports
Frequently Asked Questions
What is 4502.T's Benjamin Graham fit score?
4502.T scores 54/100 on our Benjamin Graham fit engine - grade C. Meets 4/7 Graham criteria - partially qualifies.
Does Benjamin Graham actually own 4502.T?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends 4502.T.
How often is this score updated?
4502.T's Benjamin Graham fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Key terms in this analysis
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Benjamin Graham personally owns or recommends 4502.T.